Resource Logo
AIDS Weekly Plus

Findings in AIDS/HIV Research Reported from Massachusetts General Hospital


2012 DEC 3 (NewsRx) -- By a News Reporter-Staff News Editor at AIDS Weekly -- Investigators discuss new findings in AIDS/HIV Research. According to news reporting from Boston, Massachusetts, by NewsRx journalists, research stated, "Regulatory T cells (Tregs) are potent immune modulators, but their precise role in HIV pathogenesis remains incompletely understood."

The news correspondents obtained a quote from the research from Massachusetts General Hospital, "Most studies to date have focused on frequencies or phenotypes of 'bulk' Treg populations. However, although antigen-specific Tregs have been reported in other diseases, HIV-1 epitope-specific Tregs have not been described to date."

According to the news reporters, the research concluded: "We here report the first identification of functional HIV-1-Gag-specific regulatory T cells using human leukocyte antigen class II tetramer staining in HIV-1-infected individuals."

For more information on this research see: Identification of HIV-1-specific regulatory T-cells using HLA class II tetramers. Aids, 2012;26(16):2112-2115. Aids can be contacted at: Lippincott Williams & Wilkins, 530 Walnut St, Philadelphia, PA 19106-3621, USA. (Lippincott Williams and Wilkins -; Aids -

Our news journalists report that additional information may be obtained by contacting M. Angin, Massachusetts General Hospital, Div Infect Dis, Boston, MA 02114, United States (see also AIDS/HIV Research).

Keywords for this news article include: Boston, HIV/AIDS, RNA Viruses, Retroviridae, Massachusetts, United States, HIV Infections, AIDS/HIV Research, Vertebrate Viruses, Primate Lentiviruses, North and Central America, Viral Sexually Transmitted Diseases

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2012, NewsRx LLC


Copyright © 2012 -AIDS Weekly Plus, Publisher. All rights reserved to Charles Henderson, Publisher. Permission to reproduce granted to AEGIS by Charles W. Henderson. Authorization to reproduce for personal use granted granted by C. W. Henderson, Publisher, provided that the fee of US$4.50 per copy, per page is paid directly to the Copyright Clearance Center, 27 Congress Street, Salem, Massachusetts 01970, USA. Published by Charles Henderson, Publisher. Editorial & Publishing Office: P.O. Box 5528, Atlanta, GA 30307-0528 / Telephone: (800) 633- 4931; Subscription Office: P.O. Box 830409, Birmingham, AL 35283-0409 / FAX:(205) 995-1588 Visit AIDS WEEKLY PLUS.

Information in this article was accurate in December 3, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.